Comparative Study Between Bilateral and Unilateral Spinal Anaesthesia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01877356
Recruitment Status : Terminated (intermittent evaluation of results: high incendence of complications)
First Posted : June 13, 2013
Last Update Posted : April 24, 2015
Information provided by (Responsible Party):
Dr M. B. Breebaart, University Hospital, Antwerp

Brief Summary:
The purpose of this study is to compare unilateral spinal anesthesia using hyperbaric Prilocaine with "classical bilateral spinal anesthesia" using plain Prilocaine according to block characteristics and quality of micturition, standardized to the subjects own functional bladder capacity. Our hypothesis is that unilateral spinal anesthesia will provide faster time to micturtition and discharge, lesser hypotension and lesser micturition problems.

Condition or disease Intervention/treatment Phase
Anesthesia; Adverse Effect, Spinal and Epidural Procedure: bilateral spinal anesthesia Procedure: unilateral spinal anesthesia Not Applicable

Detailed Description:

Many studies have been published in search of the ideal locoregional anesthetic for day case procedures under spinal anesthesia.

Transient neurological symptoms (TNS) and bladder retention are two side effects, which have been described in literature with incidences ranging from 0-80%.

Lidocaine, which was our hospital standard for spinal anesthesia in day case surgery, has a high incidence of TNS. Besides changing the product, dose or additive, optimisation of spinal anesthesia can be performed by changing anesthetic technique or fluid policy.

There is no consensus in literature about fluid policy and the risk of urinary retention. In a previous study we found that urge sensation and bladder capacity is subject to a high variability.

There are a few studies published about unilateral anesthesia for day-case surgery. For bilateral anesthesia it was shown that recuperation of the detrusor function comes with the regression of the sensory block to the S2 dermatome . However, little is known about bladder function during unilateral block of the sacral segments, not to mention the detrusor function and micturition with an asymmetric recovery of the sensory and motor block.

Prilocaine has found to induce reasonably short durations of spinal blockade, without causing TNS while manufactured in plain and hyperbaric solutions .

We expect that with a unilateral technique patients can void faster and can reach discharge criteria faster then with a bilateral technique.

We will compare unilateral spinal anesthesia with hyperbaric prilocaine with bilateral spinal anesthesia with plain prilocaine. The two techniques will be compared on the following subject

  • quality of the motor and sensory block
  • recovery from the sensory and motor block
  • hemoynamic changens (blood pressure and hart rate)
  • time to micturition
  • micturition quality
  • discharge time
  • complications

Sensory block will be tested by loss of cold sensation. Quality of unilateral block will be tested by QST.

Protocol for catheterisation will be adjusted according to the patients individual bladder capacitity, based on a bladder diary. Quality of micturition will be based on bladderscanning, uroflow and subjective complaints. A micturition score from one of our previous studies is used.

Two days and one week postoperative patients will be called and asked if they experienced one of the following symptoms:

  • Back pain
  • Symptoms of TNS
  • Headache
  • Micturition problems
  • Use of per oral pain medication
  • Other

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 25 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Unilateral Versus Bilateral Spinal Anesthesia in Day Case Procedures: Difference in Block Characteristics, Micturition Quality and Discharge Time
Study Start Date : December 2012
Actual Primary Completion Date : August 2014
Actual Study Completion Date : August 2014

Resource links provided by the National Library of Medicine

Drug Information available for: Prilocaine

Arm Intervention/treatment
Experimental: bilateral spinal anesthesia
bilateral spinal anesthesia prilocaine plain 20% 50 mg ambulatory surgery
Procedure: bilateral spinal anesthesia
prilocaine plain 2% 50 mg

Experimental: unilateral spinal anesthesia
unilateral spinal anesthesia prilocaine hyperbaar 2% 30 mg ambulatory surgery
Procedure: unilateral spinal anesthesia
prilocaine 2% hyperbaric 30 mg

Primary Outcome Measures :
  1. time to micturition (minutes) [ Time Frame: up to 360 minutes ]
    time to event outcome. Time from injection untill patient the moment voids for the first time (average off 4hours)

  2. discharge time ( minutes) [ Time Frame: up to 360 minutes ]
    time from injection untill dischargecriteria are reached ( average of 4 hours). Time to event outcome , event = discharge

  3. regression motor block [ Time Frame: up to 240 minutes ]
    Motor block will be assessed at regular intervals from spinal injection (t0) until total regression of the motor block.

Secondary Outcome Measures :
  1. drop blood pressure [ Time Frame: up to 240 minutes ]
    percentage drop blood pressure compared to baseline ( measured before spinal injection) Blood pressure will be measured at regular intervals from just prior to spinal injection until discharge

  2. incidence transient neurologic symptoms [ Time Frame: 1 week ]
    patients will be called at home one week postoperatively to ask for symptoms resembling transien neurological symptoms

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • spinal anaesthesia
  • surgery<60 minutes

Exclusion Criteria:

  • preexisting micturition problems
  • surgery lower abdomen/pelvis
  • bmi>30
  • mental problems
  • kidney disease
  • neurologic disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01877356

University Hospital Antwerp
Edegem, Antwerp, Belgium, 2650
Sponsors and Collaborators
University Hospital, Antwerp
Principal Investigator: margaretha breebaart, md senior member of staff department anaesthesiology
Study Director: Marcel Vercauteren, professor University Hospital, Antwerp

Responsible Party: Dr M. B. Breebaart, dr, University Hospital, Antwerp Identifier: NCT01877356     History of Changes
Other Study ID Numbers: study B300201215548
B300-2012-15-548 ( Other Identifier: BUN (belgisch uniek nummer) )
First Posted: June 13, 2013    Key Record Dates
Last Update Posted: April 24, 2015
Last Verified: April 2015

Keywords provided by Dr M. B. Breebaart, University Hospital, Antwerp:
ambulatory surgery
spinal anesthesia
bladder retention
unilateral block
prilocaine hyperbaric
prilocaine plain
local anaesthetic dose

Additional relevant MeSH terms:
Central Nervous System Depressants
Physiological Effects of Drugs
Anesthetics, Local
Sensory System Agents
Peripheral Nervous System Agents